Browsing: pfizer

Recent research from Singapore questions whether two doses of COVID-19 vaccine are sufficient for children, exploring the necessity of booster shots amid variant concerns. Since the start of the COVID-19 pandemic, extensive research in epidemiology, clinical practice, and virology has greatly increased our understanding of the virus and its impact on human health.

The US Food and Drug Administration (FDA) has greenlit new COVID-19 boosters for both Moderna and Pfizer, marking a proactive step in the fight against rapidly spreading infections in the country. Concurrently, Moderna and Pfizer have announced that their updated COVID-19 vaccines show a robust response against the BA.2.86 subvariant, a mutated version of the coronavirus.

The mechanism of action of zavegepant is based on the positive relationship4 between serum concentration of CGRP and acute migraine attacks.

Pfizer’s (RSV) vaccine has shown promising results in protecting infants and older adults from the illness caused by this virus. Read more.

As we progress into 2022, the world continues its battle against COVID-19, with yet another new strain – Omicron, that…

Myocarditis and pericarditis have been recognised as rare cardiac complications of COVID-19 mRNA vaccinations. Myocarditis is the inflammation of the…

The COVID-19 disease is a contagious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known…

Pfizer and BioNTech, makers of the COVID-19 mRNA vaccines, held a press release on Wednesday (8 Dec), saying that the…